Clindamycin and tretinoin gel is a U.S. prescription acne formulation combining a topical lincosamide antibiotic with a retinoid. Ziana labeling identifies clindamycin phosphate 1.2% and tretinoin 0.025% in a topical gel. This page explains the ingredient pairing, strengths and key label checks, not a recommendation to begin treatment. For other fixed acne options, visit the clindamycin combinations hub.
Tretinoin changes the product’s treatment rationale and counseling. It is not simply plain clindamycin gel with a different carton: skin irritation, sunlight exposure and pregnancy discussions require particular attention. The two named active ingredients must both match the prescription before a pharmacy can identify the appropriate product.
For the specific brand label, see Ziana brand details; for standalone tretinoin access, visit the topical tretinoin purchase guide. A combined formulation must be kept distinct from either single-ingredient product and from the antibiotic/benzoyl peroxide family.
The labeled combination contains clindamycin phosphate 1.2% and tretinoin 0.025%. Clindamycin is the antibiotic component; tretinoin is a topical retinoid affecting processes involved in acne. The ingredients are incorporated into one gel with formulation-specific instructions rather than purchased as a simple additive mixture.
The percentage statements also reflect label conventions for the clindamycin phosphate salt. Do not equate the number on a fixed-combination label with a bare “1% clindamycin” marketplace search or assume that all 0.025% tretinoin products are equivalent.
| Product detail | Fixed clindamycin/tretinoin gel | Do not confuse with |
|---|---|---|
| Active ingredients | Clindamycin phosphate and tretinoin | Plain clindamycin |
| Example strength | 1.2% / 0.025% | Tretinoin-only 0.025% |
| Route | Topical skin use | Oral or vaginal clindamycin |
| Second ingredient | Retinoid tretinoin | Benzoyl peroxide |
| Prescription | Valid U.S. Rx for the combination | Independent OTC products |
| Counseling | Irritation and sun-exposure precautions | Directions copied from another gel |
A retinoid combination and a benzoyl peroxide combination have different second actives and different counseling needs. Benzoyl peroxide is especially relevant to antibiotic-resistance stewardship; tretinoin creates retinoid-associated dryness, sensitivity and sun-care considerations. Clinical regimens may address resistance with other prescribed components.
The two-ingredient benzoyl peroxide guide explains the alternative formulation family without implying that one fixed product can be substituted for the other at checkout.
Ziana is a labeled U.S. combination gel with 1.2% clindamycin phosphate and 0.025% tretinoin. Its prescribing information includes topical-use instructions and an indication for acne vulgaris in patients age 12 and older. The separate brand page covers its full product identity.
The existence of a brand label does not demonstrate what a particular pharmacy currently has in stock. Confirm current marketed package details and any appropriate generic product with the pharmacist.
When a clinician orders the combination, the pharmacist needs to check that both ingredients, both percentages, gel route and dispensing package match the order. An abbreviated listing that shows only “clindamycin gel” or only “tretinoin 0.025%” is incomplete.
The pharmacy availability guide explains how to verify a specific product rather than infer stock from a catalogue entry. If the preferred brand differs from the order, ask the pharmacist about permitted substitution.
Tretinoin-containing combinations can cause redness, peeling, burning, stinging or dryness, especially when other drying treatments are used. Ziana’s label cautions about sunlight and sunlamps and calls for attention to sun protection. A clinician may adjust the overall skin-care plan according to tolerability.
Patients should not add exfoliating scrubs, strong peeling products or extra retinoids without discussing cumulative irritation. A two-ingredient prescription tube does not remove the need for basic gentle skin-care counseling.
Pregnancy status and pregnancy planning warrant discussion before a tretinoin-containing prescription is used. The data and label precautions for a topical fixed combination should not be replaced with assumptions derived from oral retinoids or from a different product.
A clinician can review benefits, uncertainties and alternative acne options for the individual situation. The pregnancy and breastfeeding overview covers clindamycin-route considerations but does not substitute for retinoid-specific counseling.
The topical route does not eliminate antibiotic-related precautions. Ziana labeling warns that clindamycin absorption can occur and that severe diarrhea or colitis is possible. It also lists particular inflammatory bowel conditions or antibiotic-associated colitis history among contraindications.
Tell the prescriber about past serious antibiotic diarrhea, bowel disease or allergy. Significant diarrhea while using a clindamycin-containing gel warrants stopping use and prompt clinical evaluation according to the product instructions.
ZIANA prescribing information explicitly contraindicates the gel in patients with regional enteritis, ulcerative colitis, or a history of antibiotic-associated colitis. Significant diarrhea calls for stopping the product and obtaining clinical evaluation. These are label requirements for the fixed combination and should not be reduced to a general reminder to discuss stomach upset.
ZIANA labeling also says not to combine this clindamycin-containing gel with erythromycin-containing products, and advises caution with additional topical products that have strong drying effects. A medication review should check every prescription and nonprescription acne product before treatment starts.
A prescription gel has a defined vehicle and proportions; combining a clindamycin tube with a separate tretinoin cream cannot be assumed to reproduce it. Different vehicles may change application, tolerability or other formulation characteristics.
If a clinician prescribes independent products, that plan requires its own directions. Our single-ingredient clindamycin gel guide addresses a separate dosage form and should not be used as combination instructions.
A generic or alternative product can be reviewed only against the full ingredient pair, strength, dosage form and prescription. A brand reference is useful, but product-specific labeling and lawful pharmacy substitution rules determine what may actually be dispensed.
Ask the pharmacist to explain differences in package, manufacturer and inactive formulation when they affect patient use. Do not assume a brand’s current availability from a historical label or online search snippet.
A fixed combination may be covered differently from separate clindamycin and tretinoin prescriptions. Plan benefits, brand versus generic status, pharmacy network and package size can all alter out-of-pocket cost, even when the active components sound similar.
Ask for the current exact-product quote and whether prior authorization or preferred alternatives apply. General cost drivers are described in the topical clindamycin pricing guide, without inventing an average retail dollar amount.
Dermatology treatment guidance helps explain the role of retinoids and antibiotics in acne care, but an individual’s severity, previous treatments, other medicines and pregnancy considerations drive the specific prescription. A site should not imply that a fixed formula is the correct next step for everyone.
Treatment selection and antibiotic stewardship are discussed separately in clindamycin for acne. This product page concentrates on recognizing a clindamycin/tretinoin fixed formulation.
Verify both ingredient names, 1.2%/0.025% labeled strength if prescribed, topical gel route and package-specific warnings. Ask the clinician or pharmacist about skin irritation, sun exposure and use of other acne medications.
A licensed pharmacy and valid prescription are essential. See the seller-verification checklist when considering an online source; no retailer, stock promise or guaranteed outcome is endorsed.
A fixed prescription topical acne product containing both clindamycin phosphate and the retinoid tretinoin.
Clindamycin phosphate 1.2% and tretinoin 0.025% in a topical gel.
No. Tretinoin is an additional active ingredient with distinct benefits and precautions.
No. The fixed combination requires a valid prescription in the United States.
No. One contains tretinoin and the other benzoyl peroxide. Both ingredients and formulations differ.
Retinoid-containing products have sun-exposure precautions. Review the exact prescribed label and clinician advice.
Contact the prescribing clinician promptly to review the tretinoin-containing medication and available options.
Do not attempt to recreate a fixed prescription formulation by mixing separate products.
Clindamycin can be absorbed from topical products, and labels warn about antibiotic-associated diarrhea and colitis.